Prenatal Screening for Anticardiolipin Antibody

American Journal of Perinatology

Volumn 7, Issue 3, 1990, Pages 245-250

  Bendon, Robert W ^a   Hayden, Linda E ^a   Hurtubise, Paul E ^a   Getahun, Berhanu ^a   Siddiqi, Tariq A ^a   Glueck, Helen I ^a   Luggen, Michael E ^a   Gartside, Peter S ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY BLOOD LEVEL; CONFERENCE PAPER; DIAGNOSTIC VALUE; FEMALE; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST;

EID: 0025338491     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-2007-999492     Document Type: Article

References (19)

1. Lockshin M.D., et al: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 313:152–156, 1985
2. Harris E.N., et al: Anticardiolipin antibodies: Detection by radioimmunoassay and associated with thrombosis in systemic lupus erythematosus. Lancet 2:1211–1214, 1983
3. Eswaran K., Rosen S.W.: Recurrent abortions, thromboses, and a circulating anticoagulant. Am J Obstet Gynecol 151:751–752, 1985
4. De Wolf F., et al: Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 142:829–834, 1982
5. Lubbe W.F., et al.: Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1:1361–1363, 1983
6. Branch D.W., et al: Obstetric complications associated with the lupus anticoagulant, N Engl J Med 313:1322–1326, 1985
7. Bendon R.W., Wilson J., Getahun B., van der Bel-Kahn J.: A maternal death due to thrombotic disease associated with anticardiolipin antibody. Arch Pathol Lab Med 111:370–373, 1987
8. Gharvi A.E., et al: Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 46:1–6, 1987
9. Cowchock S., Smith J.B., Gocial B.: Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 155:1002–1010, 1986
10. Harris E.N., Gharaci A.E., Patel S.P., Hughes G.R.V.: Evaluation of the anticardiolipin antibody test: Report of an international workshop held 4 April 1986, Clin Exp Immunol 68:215–222, 1987
11. Quick A.J.: Hemorrhagic Disease. Philadelphia: Lee & Febiger, 1967, p 379
12. Sirridge M.S.: Laboratory Evaluation of Hemostasis. Philadelphia: Lea & Febiger, 1967, p 92
13. Glueck H.I., Kant K.S., Weiss M.S., Pollak V.E., Miller M.A., Coots M.: Thrombosis in systemic lupus erythematosus relation to the presence of circulating anticoagulants. Arch Intern Med 145:1389–1395, 1985
14. 3H) sulfate. Clin Exp Immunol 4:527–536, 1969
15. McIntyre J.A., Faulk W.P., Verhulst S.J., Colliver J.A.: Human trophoblast-lymphocyte cross-re active (TLX) antigens define a new alloantigen system. Science 222:1135–1137, 1983
16. 1RNP (n RNP) antibodies. N Engl J Med 316:1135–1138, 1987
17. Smeenk R.J.T., Lucassen W.A.M., Swaak T.J.G.: Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity? Arthritis Rheum 30:607–617, 1987
18. Petri M., Golbus M., Anderson R., Whiting-O'Keefe Q., Corash L., Hellman D.: Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. Arthritis Rheum 30:601–606, 1987
19. Koskela P., Vaaralo O., Makitalo R., Palosuo T., Aho K.: Significance of false positive syphilis reactions and anticardiolipin antibodies in a nationwide series of pregnant women. J Rheum 15:70–73, 1988